fda tirzepatide approval approves new version of diabetes drug Mounjaro to be sold for weight loss The FDA approved Zepbound (tirzepatide)

Examples include peptide tyrosine tyrosine (PYY), pancreatic polypeptide, cholecystokinin (CCK), GLP-2 and secretin, which suppress food intake, mostly via centrally mediated mechanisms [72,73,74,75,76]

Weight loss typically begins in the first few weeks and continues steadily throughout treatment

That kind of indirect behavioral effect doesnt show up in pharmacology textbooks, but its real and worth anticipating

Broader Acceptance and Use: As more data becomes available, compounded semaglutide could gain broader acceptance among healthcare providers and patients

In certain cases, usually for medical reasons such as an allergy, an insurer will make an exception to reimburse the full price of a brand-name drug